NASDAQ · Biotechnology

GLSI (GLSI) Stock

$14.36 +0.84% NASDAQ: GLSI Healthcare

Valuation

MetricValue
Price$14.36
Market Cap$210.78M
P/E Ratio-21.98
P/B Ratio122.80
P/S Ratio0.00
EPS (TTM)$-1.21
52-Week High$34.10
52-Week Low$7.78
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-533.33%
ROA-400.00%
ROCE-800.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio2.00

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$0$0
Operating Profit$-2.0M$-5.0M$-8.0M$-9.0M$-16.0M
Net Profit$-2.0M$-5.0M$-8.0M$-9.0M$-16.0M
EPS$-0.15$-0.35$-0.61$-0.69$-1.21
Op Margin—————

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$29.0M$27.0M$13.0M$7.0M$4.0M
Total Liabilities$1.0M$0$0$0$2.0M
Cash$29.0M$27.0M$13.0M$7.0M$4.0M
Borrowings$0$0$0$0$0

Latest News

Greenwich LifeSciences Says EU Regulator Approves Combination of HLA Patients in Phase 3 Trial MT Newswires · Jul 16, 2026 Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01 GlobeNewswire · Jul 16, 2026 Sector Update: Healthcare Stocks Mixed Pre-Bell Thursday MT Newswires · Jul 9, 2026 Sector Update: Healthcare MT Newswires · Jul 9, 2026 Greenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01 GlobeNewswire · Jul 9, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-1.0M$-4.0M$-6.0M$-6.0M$-7.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$-8.0M$0$0
Net Cash Flow$29.0M$-1.0M$-14.0M$-6.0M$-3.0M
Free Cash Flow$-1.0M$-4.0M$-6.0M$-6.0M$-7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-2.30%
Quick Ratio2.35
Interest Coverage—
Return 1Y75.86%
Return 3Y103.53%
Return 5Y-54.65%

Ownership

Insiders Held47.86%
Institutions Held12.48%
Institutions Float Held23.93%
Institutional HolderSharesReport Date
Blackrock Inc.433,8602026-03-31
Vanguard Capital Management LLC298,2662026-03-31
Geode Capital Management, LLC155,4662026-03-31
State Street Corporation133,8752026-03-31
Nuveen, LLC88,7172026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AGENAgenus Inc. $6.06 +1.34% 3.46 $252.35M 0.00%
ATOS $2.36 -2.48% -1.23 $23.54M 0.00%
CGTX $0.89 +0.21% -3.94 $79.79M 0.00%
HURA $2.09 -2.34% -3.75 $133.10M 0.00%
IMMX $8.55 +4.65% -9.96 $465.14M 0.00%

About GLSI

GLSI is led by CEO Snehal S. Patel, employs 4 people, headquartered in US, publicly traded since 2020.

GLSI stock trades at $14.36 with a market capitalization of $210.78M. The stock is valued at a price-to-earnings (P/E) ratio of -21.98, price-to-book of 122.80, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $7.78 and $34.10, and currently trades 57.9% below its 52-week high.

On profitability, GLSI generates a return on equity (ROE) of -533.33%, return on capital employed of -800.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides